critic
molecular
cellular
biolog
factor
impact
design
licens
dna
vaccin
vector
combin
high
yield
integr
bacteri
product
increas
express
mammalian
cell
review
food
drug
administr
fda
world
health
organ
european
medic
agenc
emea
regulatori
guidanc
discuss
relat
vector
design
plasmid
ferment
new
vector
requir
extens
preclin
test
valid
safeti
perform
prior
clinic
use
regulatori
test
burden
followon
product
reduc
combin
care
design
synthet
gene
exist
valid
vector
backbon
flowchart
creation
new
synthet
gene
combin
rational
design
bioinformat
present
biolog
plasmid
replic
review
process
engin
strategi
reduc
metabol
burden
discuss
util
recent
develop
low
metabol
burden
seed
stock
ferment
strategi
optim
vector
manufactur
high
yield
exceed
gl
specif
plasmid
yield
total
dri
cell
weight
plasmid
dna
new
gener
biotechnolog
product
gene
medicin
dna
vaccin
begin
enter
marketplac
plasmid
dna
vector
may
find
applic
prevent
therapeut
dna
vaccin
viral
bacteri
parasit
diseas
indic
cancer
gene
therapi
product
four
dna
plasmid
product
current
licenc
veterinari
applic
includ
two
infecti
diseas
vaccin
west
nile
viru
hors
ft
dodg
anim
health
infecti
haematopoiet
necrosi
viru
salmon
novarti
well
melanoma
cancer
vaccin
dog
merial
growth
hormon
releas
factor
therapi
pig
vgx
anim
health
approv
numer
human
plasmid
product
pipelin
recent
review
phase
phase
ii
phase
iii
human
dna
vaccin
clinic
trial
identifi
kutzler
weiner
vector
util
ongo
trial
often
util
gener
cmv
promot
contain
vector
deriv
vical
vector
hartikka
et
al
howev
correspond
author
jame
william
natur
technolog
corpor
innov
drive
lincoln
nebraska
telephon
immunogen
vector
human
larg
anim
gener
low
inde
approv
veterinari
vaccin
cite
highli
immunogen
target
antigen
improv
express
often
critic
vaccin
perform
murin
model
increas
express
correl
improv
immunogen
larg
anim
human
kutzler
weiner
gener
applic
larg
anim
rang
antigen
target
gene
express
need
increas
well
vector
invitrogen
carlsbad
ca
optim
product
yield
poor
product
yield
impos
signific
addit
cost
post
licensur
review
herein
improv
vector
design
critic
ensur
safeti
efficaci
cost
effect
manufactur
new
gener
vaccin
product
applic
plasmid
dna
involv
four
gener
stage
figur
first
plasmid
encod
gene
interest
transform
bacteri
cell
typic
escherichia
coli
e
coli
propag
make
master
work
cell
bank
propag
bioreactor
make
product
cell
contain
high
yield
plasmid
stage
second
product
cell
lyse
plasmid
dna
purifi
util
one
plural
purif
method
review
shamlou
carn
william
prather
et
al
formul
deliveri
stage
third
plasmid
deliv
eukaryot
cell
use
one
plural
deliveri
method
stage
review
kutzler
weiner
final
stage
gene
interest
express
vector
backbon
stimul
innat
immun
respons
unmethyl
cpg
gatc
sequenc
gener
b
dna
mediat
type
interferon
activ
review
takeshita
ishii
wagner
stage
surprisingli
gener
part
singl
purif
process
formul
deliveri
method
appli
without
modif
new
unrel
vector
smaller
vector
potent
larg
vector
bloquel
et
al
purif
step
ion
exchang
membran
separ
perform
well
larg
plasmid
gener
effect
sequenc
specif
contrast
stage
sensit
vector
chang
dna
vaccin
plasmid
contain
function
element
afford
propag
replic
origin
select
eg
antibiot
resist
bacteri
host
organ
element
drive
high
level
express
eukaryot
host
express
cassett
compris
eukaryot
enhanc
promot
termin
polyadenyl
signal
activ
innat
immun
compon
must
care
arrang
sinc
slight
modif
vector
enhanc
one
paramet
multipl
undesir
effect
paramet
herein
vector
design
criteria
optim
plasmid
perform
bacteria
stage
eukaryot
stage
cell
extens
review
research
wish
clone
new
gene
exist
vector
flowchart
design
synthesi
optim
gene
insert
present
final
high
yield
plasmid
ferment
process
review
promis
new
low
metabol
burden
fedbatch
ferment
strategi
highlight
vector
modif
improv
antigen
express
eg
codon
optim
inclus
intron
strong
promot
highli
correl
improv
immun
respons
review
manoj
et
al
antigen
express
affect
follow
compon
dna
vaccin
tradit
incorpor
human
cytomegalovirusimmediateearli
actin
cagg
promot
promot
drive
higher
constitut
express
level
altern
viral
promot
eg
cellular
promot
human
ubiquitin
c
ubc
human
elong
factor
factor
promot
howev
improv
express
beyond
current
cmv
cagg
base
vector
may
improv
immunogen
human
may
obtain
util
modifi
cmv
promot
exampl
incorpor
region
downstream
cmv
promot
increas
express
improv
cellular
immun
respons
hiv
dna
vaccin
mice
nonhuman
primat
cmvr
promot
barouch
et
al
humor
respons
influenza
hemagluttinin
dna
vaccin
luke
et
al
william
improv
express
andor
immunogen
also
observ
chimer
promot
li
et
al
william
li
et
al
review
kutzler
weiner
figur
express
gener
higher
intron
present
typic
includ
vector
backbon
downstream
promot
part
mrna
leader
separ
exon
exon
figur
typic
arrang
kozak
consensu
sequenc
kozak
start
exon
immedi
prior
atg
start
codon
splice
untransl
leader
region
utr
typic
basepair
bp
long
optim
limit
secondari
structur
especi
affect
atg
remov
upstream
atg
start
codon
rnasel
substrat
cluster
singl
strand
uu
ua
motif
express
typic
higher
gene
codon
optim
match
target
organ
termin
dual
stop
codon
limit
read
translat
transcript
terminatorspolyadenyl
signal
deriv
bovin
growth
hormon
rabbit
gene
commonli
util
dna
stop
codon
termin
limit
reduc
possibl
cryptic
peptid
express
unintend
micrornamedi
express
alter
develop
pdnavaccultra
hartikka
et
al
determin
gene
express
eukaryot
cell
cmv
promot
dramat
affect
alter
vector
sequenc
close
proxim
cmv
enhanc
number
prokaryot
sequenc
shown
neg
affect
gene
express
eukaryot
cell
leit
et
al
b
peterson
et
al
bind
eukaryot
transcript
factor
tulli
cidlowski
ghersa
et
al
kushner
et
al
may
account
express
level
depend
composit
orient
element
within
prokaryot
region
especi
immedi
vicin
eukaryot
express
cassett
sequenc
chang
made
plasmid
backbon
need
care
evalu
detect
unexpect
detriment
effect
modif
intend
purpos
vector
certain
sequenc
promot
dna
unwind
separ
stand
cruciform
cruciform
confer
sensit
endonucleas
mung
bean
endonucleas
nucleas
present
eukaryot
lysosom
compart
region
reduc
stabil
plasmid
traffick
nucleu
endosom
due
nick
acid
endonucleas
cruciform
occur
promot
termin
region
invert
repeat
eg
replic
origin
homopurin
segment
sequenc
promot
secondari
structur
comput
program
util
identifi
potenti
cruciform
cleavag
hot
spot
eg
websidd
bi
betham
interestingli
plasmid
invitrogen
carlsbad
ca
bovin
growth
hormon
termin
region
contain
homopurin
region
nucleas
sensit
altern
polya
sequenc
significantli
improv
plasmid
nucleas
stabil
express
transfect
reduc
indic
polyadenyl
effici
epistat
nucleas
resist
azzoni
et
al
interestingli
studi
supercoil
plasmid
stabil
thermal
degrad
rate
increas
plasmid
contain
nucleas
sensit
homopurin
region
ribeiro
et
al
see
middaugh
et
al
review
plasmid
degrad
pathway
test
method
replic
origin
contain
strong
cruciform
sensit
region
endonucleas
attack
plasmid
elimin
region
minicircl
vector
may
part
account
improv
express
vector
minicircl
vector
incorpor
target
sequenc
site
specif
recombinas
flank
replic
origin
select
marker
vector
backbon
express
recombinas
post
propag
recombin
vector
two
minicircl
vector
eukaryot
express
cassett
minicircl
purifi
away
bacteri
origin
select
marker
contain
minicirl
review
darquet
et
al
signific
product
issu
need
overcom
cost
effect
manufactur
minicircl
vector
use
recombinas
enzym
review
summari
minor
variat
vector
backbon
alter
express
level
alter
target
protein
intracellular
local
ramanathan
et
al
ultim
modifi
immun
respons
zinckgraf
silbart
adapt
immun
respons
enhanc
improv
antigen
process
mhci
mhcii
present
review
leifert
et
al
accomplish
target
heterolog
protein
variou
intracellular
destin
exampl
use
tissu
plasminogen
activ
signal
sequenc
tpa
direct
antigen
secret
often
enhanc
immun
respons
zhongm
et
al
well
membraneanchor
use
human
alkalin
phosphatas
plap
gerber
et
al
endosom
target
use
human
wu
et
al
august
et
al
weiss
et
al
proteosom
target
use
murin
ubiquitin
rodriguez
et
al
delogu
et
al
endoplasm
reticulum
target
xu
et
al
may
alter
enhanc
immun
respons
endosom
target
promot
mhc
class
ii
respons
destabil
ubiquitin
molecul
versu
nativ
util
enhanc
entri
proteosom
degrad
pathway
increas
mhc
class
present
promot
thelper
h
bias
immun
respons
endosom
target
de
arruda
et
al
secret
qiu
et
al
shown
enhanc
immun
respons
gag
protein
dendrit
immun
cell
target
varieti
leader
peptid
tag
dramat
improv
antibodi
respons
exampl
dendrit
cell
target
shown
improv
antibodi
respons
plasmid
dna
deliv
gene
gun
pig
tachedjian
et
al
tag
extracellular
domain
human
highli
relat
protein
eg
iggfc
lselectin
review
manoj
et
al
could
potenti
promot
autoimmun
respons
immunostimulatori
sequenc
unmethyl
cpg
util
enhanc
lymphocyt
recruit
expans
innat
immun
respons
cpg
motif
fold
underrepres
mammalian
genom
dna
present
often
methyl
unmethyl
cpg
bacteri
dna
plasmid
stimul
h
bias
immun
respons
toll
like
receptor
may
contribut
potenc
plasmid
base
dna
vaccin
limit
durat
express
unmethyl
cpg
potenc
affect
flank
dinucleotid
context
krieg
immunostimulatori
cpg
content
plasmid
increas
increas
cpg
content
throughout
plasmid
krieg
et
al
ad
block
cpg
non
essenti
region
applic
gene
replac
therapi
shrna
mediat
gene
express
knockdown
immun
stimul
short
term
express
undesir
promot
protein
select
marker
gene
modifi
reduc
elimin
cpg
motif
although
origin
deriv
puc
origin
contain
multipl
cpg
motif
difficult
remov
without
disrupt
origin
function
cpg
reduc
plasmid
creat
therapeut
use
krieg
et
al
yew
et
al
applic
unmethyl
cpg
undesir
altern
origin
modifi
host
strain
overproduc
cpg
methylas
crouzet
cameron
consid
cpg
free
plasmid
vector
incorpor
cpg
free
version
origin
bacteri
promot
express
zeomycin
resist
gene
mammalian
promot
leader
termin
commerci
avail
pcpg
invivogen
san
diego
ca
therapeut
use
zeomycin
could
replac
codonoptim
cpg
free
version
kanamycin
resist
marker
altern
marker
howev
innat
immun
respons
plasmid
elimin
remov
cpg
cytoplasm
local
bdna
also
induc
innat
pattern
receptor
implic
key
compon
activ
immun
respons
plasmid
dna
vaccin
review
takeshita
ishii
recent
wagner
propos
activ
cpg
contain
synthet
dna
phosphothio
base
depend
recognit
unmodifi
dna
may
sequenc
independ
consid
minor
alter
vector
sequenc
dramat
affect
express
see
section
immunogen
see
section
immunostimulatori
alter
result
vector
backbon
cpg
alter
need
care
interpret
ensur
result
due
secondari
effect
express
methyl
alter
dcm
gene
encod
dna
methylas
methyl
intern
cytosin
residu
recognit
sequenc
dam
methylas
encod
dna
methylas
methyl
intern
adenosin
recognit
sequenc
n
methyladenosin
well
e
coli
e
coli
b
encod
type
restrict
enzym
hsdrm
methylas
enzym
methyl
intern
adenosin
recognit
sequenc
respect
import
sinc
methyl
pattern
found
vertebr
confer
bacteri
signatur
dna
prepar
e
coli
may
affect
express
ormak
prone
recognit
foreign
dna
host
innat
immun
system
describ
expressionmethyl
plasmid
dna
dam
dcm
site
alter
express
promot
studi
specif
manner
express
mammalian
cell
equival
dam
dcm
versu
damdcmplasmid
dna
use
either
cmv
promot
vector
cmv
promot
vector
drive
express
methyl
downstream
gene
lai
et
al
contrast
result
separ
studi
wherein
cmv
promot
express
higher
vivo
electropor
mice
dam
dcm
methyl
plasmid
compar
damdcmunmethyl
plasmid
allaman
et
al
cmv
promot
driven
express
also
slightli
lower
unmethyl
plasmid
versu
dam
dcm
methyl
iv
hydrodynam
lipofect
deliveri
mice
ochiai
et
al
cmv
promot
contain
dcm
dam
site
increas
express
mice
methyl
dna
may
secondari
effect
perhap
promot
stimul
due
dam
methylationmedi
cytokin
induct
see
section
contrast
lai
et
al
demonstr
express
altern
promotersenhanc
contain
multipl
dam
dcm
site
reduc
mammalian
cell
dam
dcm
methyl
plasmid
compar
unmethyl
version
may
direct
effect
methylationmedi
inhibit
transcript
factor
bind
promot
interest
determin
individu
contribut
dam
dcm
methyl
promot
specif
effect
final
effect
dam
dcm
methyl
statu
plasmid
transgen
silenc
liver
deliveri
observ
chen
et
al
differ
damdcmunmethyl
damdcm
methyl
plasmid
observ
macrophag
activ
robert
et
al
independ
activ
human
neutophil
trevani
et
al
contrast
oligonucleotid
plasmid
dna
contain
n
methyladenosin
increas
cytokin
induct
mice
compar
unmethyl
control
dna
tsuchiya
et
al
induct
fold
lower
unmethyl
plasmid
versu
dam
dcm
methyl
iv
hydrodynam
lipofect
deliveri
mice
ochiai
et
al
dam
methyl
product
n
wide
spread
bacteri
signatur
present
mammalian
cell
may
pattern
recogn
compon
innat
immun
system
less
like
dcm
methyl
restrict
e
coli
close
relat
gram
neg
organ
gomezeichelman
et
al
creat
common
mammalian
pattern
cpg
site
howev
dcm
methyl
cytosin
differ
context
bacteria
compar
mammal
ct
ca
sequenc
rather
cg
summari
import
determin
optim
methyl
pattern
eukaryot
cell
function
maintain
preclin
clinic
develop
cytoplasm
pattern
receptor
retino
acidinduc
gene
rigi
doublestrand
rnadepend
protein
kinas
pkr
melanoma
differentiationassoci
gene
activ
interferon
activ
doubl
strand
rna
dsrna
rna
polymeras
iii
promot
may
integr
vector
backbon
use
creat
cytoplasm
export
uncap
triphosph
doubl
strand
rna
dsrna
triphosph
dsrna
ligand
retino
acidinduc
gene
rigi
doublestrand
rnadepend
protein
kinas
pkr
activ
affect
plasmid
immunostimul
william
william
circular
bacteri
plasmid
replic
theta
strand
displac
roll
circl
mechan
see
del
solar
et
al
comprehens
review
date
gene
therapi
plasmid
util
theta
replic
origin
theta
replic
requir
synthesi
primer
rna
dna
synthesi
initi
extens
rna
primer
type
replic
character
separ
dna
strand
origin
creat
characterist
thetashap
replic
bubbl
theta
plasmid
deriv
see
requir
plasmidencod
rep
initi
protein
bind
specif
sequenc
often
tandem
direct
repeat
call
iteron
replic
origin
recruit
host
dnaa
initi
protein
flank
dnaa
box
prime
replic
vast
major
therapeut
plasmid
current
use
deriv
puc
plasmid
use
high
copi
deriv
origin
close
relat
origin
replic
plasmid
dna
synthesi
unidirect
figur
requir
plasmid
born
initi
protein
lead
strand
rna
polymeras
transcript
rnaii
form
rloop
rna
dna
hybrid
cleav
rnase
h
result
oh
serv
primer
dna
pol
direct
dna
synthesi
dna
synthesi
convert
dna
pol
iii
replic
lead
strand
expos
type
primosom
assembl
site
lag
strand
pasbl
figur
bind
pria
recruit
prib
dnat
dnab
dnac
form
preprimosom
primas
dnag
make
short
rna
substrat
dna
pol
iii
pric
may
also
involv
pathway
lag
strand
replic
initi
pasbl
termin
termin
site
ter
within
origin
lead
strand
synthesi
dnab
dnac
bound
poliii
gener
lag
strand
okazaki
fragment
everi
kb
proce
around
plasmid
stop
ter
site
review
masai
arai
plasmid
copi
number
control
rnai
antisens
rna
review
del
solar
et
al
prather
et
al
rnai
form
trna
like
structur
three
stem
loop
end
primer
rnaii
complementari
rnai
form
three
loop
structur
antisens
rnai
rnai
interact
initi
complementari
unpair
loop
rnaii
kiss
interact
review
wagner
brantl
prevent
matur
replic
primer
figur
antisens
regul
copi
number
uncharg
trna
observ
amino
acid
starvat
lead
express
stringent
wild
type
relax
rela
respons
rela
strain
uncharg
trna
elev
condit
amino
acid
limit
starv
stationari
phase
cell
bind
uncharg
trna
loop
rnai
andor
rnaii
prevent
rnai
interact
rnaii
increas
plasmid
copi
number
increas
copi
number
fold
amino
acid
starv
stationari
phase
cell
versu
log
phase
cell
amplifi
amplifi
schroeter
et
al
amplif
exploit
increas
yield
ferment
cultur
hofmann
et
al
wang
et
al
tabl
list
replic
origin
high
copi
number
modif
may
util
therapeut
dna
vaccin
plasmid
pcpg
invivogen
san
diego
ca
pcor
vector
soubrier
et
al
contain
core
origin
bp
ori
plasmid
protein
mutat
increas
copi
number
integr
host
chromosom
soubrier
et
al
tabl
design
restrict
host
rang
plasmid
specif
product
strain
plasmid
multimer
pcor
vector
occur
constitut
high
copi
number
resolv
inclus
cer
resolut
multim
site
plasmid
commonli
util
copi
deriv
origin
eg
linchao
et
al
origin
wong
et
al
approxim
kb
delet
accessori
rop
rom
protein
addit
temperatur
sensit
alter
eg
puc
destabil
rnairnaii
interact
shift
cultur
contain
origin
lead
fold
increas
plasmid
copi
number
perhap
due
addit
regul
uncharg
trna
bind
amino
acid
starvat
condit
mani
deriv
maxim
induc
temperatur
entri
stationari
phase
puc
linchao
et
al
wong
et
al
induc
plasmid
copi
number
replic
origin
prefer
plasmid
product
sinc
constitut
high
plasmid
level
increas
metabol
burden
cell
may
result
instabl
multimer
lower
product
toxic
cell
see
section
exist
dna
vaccin
plasmid
incorpor
either
base
origin
roppuc
origin
base
origin
tabl
runaway
temperatur
sensit
deriv
isol
spontan
well
ration
design
includ
highest
copi
number
runaway
replic
vector
dna
vaccin
vector
incorpor
induc
high
copi
rplasmid
origin
develop
hamann
et
al
tabl
howev
rplasmid
larg
therapeut
use
exampl
basic
replicon
kb
temperatur
induc
lambda
p
r
promot
control
origin
kb
therapeut
plasmid
stabli
monomer
resist
multimer
recombin
profici
host
plasmid
multimer
may
control
inclus
multim
resolut
system
mr
util
site
specif
recombinas
resolv
plasmid
multim
monom
review
summer
standard
puc
deriv
dna
vaccin
vector
contain
mr
sequenc
strict
control
multimer
requir
accomplish
propag
recahost
sinc
plasmid
recombin
requir
recf
pathway
requir
reca
howev
oligom
form
reca
independ
pathway
exampl
rece
pathway
sbca
mutant
fishel
et
al
degre
oligomer
higher
plasmid
contain
larg
insert
berg
et
al
direct
repeat
ribeiro
et
al
multim
form
stabli
inherit
outcompet
monom
dimer
catastroph
hypothesi
summer
et
al
although
runaway
multimer
balanc
dimer
mediat
reduc
growth
rate
bacteria
format
seed
stock
low
temperatur
demonstr
reduc
puc
plasmid
multimer
subsequ
bioreactor
product
carn
et
al
potenti
reduc
metabol
burden
stationari
phase
so
induct
lee
et
al
high
copi
pucderiv
dna
vaccin
plasmid
also
activ
partit
function
precis
distribut
cell
divis
consequ
plasmidfre
cell
aris
continu
cultur
plasmid
encod
activ
partit
function
ensur
plasmid
stabil
review
zielenkiewicz
ceglowsik
howev
inclus
partit
function
therapeut
plasmid
would
requir
consider
addit
dna
exampl
two
protein
para
parb
cisact
site
par
requir
partit
well
partit
plasmid
gener
moder
high
copi
number
consequ
therapeut
plasmid
select
marker
includ
plasmid
ensur
plasmid
retent
antibiot
resist
marker
commonli
util
select
marker
altern
select
strategi
design
address
concern
regard
dissemin
antibiot
resist
gene
patient
enter
bacteria
well
reduc
size
prokaryot
portion
therapeut
plasmid
exampl
replac
kb
kanamycin
resist
kanr
gene
potenti
increas
bioavail
decreas
plasmid
size
variou
select
system
discuss
also
see
kanr
commonli
util
antibiot
resist
marker
version
gene
without
cpg
motif
made
synthet
purchas
eg
pcpgvitroneomc
vector
invivogen
san
diego
ca
ampicillin
resist
accept
due
concern
hyper
reactiv
patient
lactam
antibiot
tetracyclin
resist
marker
toxic
e
coli
host
high
copi
number
andor
stationari
phase
chiang
bremer
valenzuela
et
al
b
system
essenti
condit
essenti
gene
present
plasmid
backbon
plasmid
select
maintain
bacteri
host
strain
contain
correspond
chromosom
delet
suppress
mutat
essenti
gene
numer
exampl
exist
system
elimin
need
antibiot
resist
marker
plasmid
often
small
ie
bp
trna
gene
exampl
pcor
vector
use
suppressor
trna
select
marker
suppress
host
chromosom
arg
gene
mutat
requir
growth
minim
media
soubrier
et
al
case
oper
sequenc
place
multicopi
plasmid
derepress
chromosom
gene
number
repressoroper
system
could
util
avail
review
eastman
durland
exampl
lac
oper
tet
oper
may
plasmid
antibiot
gene
regul
relev
oper
chromosom
titrat
repressor
oper
lead
express
chromosom
gene
antibiot
resist
therapeut
plasmid
incorpor
origin
replic
kanr
marker
eg
deriv
util
repressor
titrat
select
eg
develop
eastman
durland
altern
system
cranenburgh
et
al
dapd
essenti
chromosom
gene
control
lac
operatorpromot
three
copi
lac
oper
plasmid
titrat
lac
repressor
allow
express
dapd
absenc
multicopi
plasmid
dapd
express
repress
cell
die
advantag
system
small
size
three
copi
lac
oper
elimin
antibiot
resist
case
dapd
express
factor
may
safeti
concern
sherratt
et
al
potenti
disadvantag
system
promoteroper
complex
shown
interfer
dna
replic
mcglynn
guy
ferment
yield
oper
titrat
plasmid
report
plasmid
stabil
system
wherein
fplasmid
ccd
antidotepoison
operon
modifi
plasmid
select
report
szpirer
milinkovitch
antidot
protein
gene
ccda
incorpor
onto
plasmid
ccdb
poison
gene
express
chromosom
scheme
allow
plasmid
stabil
system
contain
protein
base
select
marker
ccda
evalu
high
yield
plasmid
ferment
two
group
develop
rna
base
select
system
util
endogen
rnai
rnaii
antisens
regul
origin
exampl
chromosom
gene
engin
contain
rnaii
sequenc
within
untransl
region
mrna
presenc
type
plasmid
abundantli
express
plasmid
encod
rnai
repressor
bind
plasmid
encod
rnaii
ectop
chromosom
express
rnaii
sequenc
latter
rnai
rnaii
bind
suppress
translat
chromosom
gene
rnarna
antisens
regul
regul
gene
antibiot
resist
marker
transcript
repressor
control
express
second
gene
lethal
gene
grabherr
pfaffenzel
cranenburgh
system
limit
exist
type
origin
contain
plasmid
vector
recent
new
rna
base
antibioticfre
select
system
report
luke
et
al
william
vector
incorpor
express
bp
antisens
rna
repress
express
chromosom
integr
constitut
express
counterselect
marker
bacillu
subtili
levansucras
sacb
allow
plasmid
select
sucros
sucros
select
dna
vaccin
vector
figur
combin
antibioticfre
select
chimer
eukaryot
promot
optim
contain
mrna
leader
highli
product
ferment
manufactur
gl
plasmid
dna
yield
therapeut
plasmid
vector
must
combin
bacteri
eukaryot
compon
describ
vector
combin
high
mammalian
express
high
copi
number
high
supercoil
effect
multim
resolut
meet
manufactur
efficaci
qualiti
requir
pharmaceut
vector
difficult
design
sinc
discuss
numer
factor
affect
critic
attribut
exampl
plasmid
copi
number
probabl
set
effici
replic
origin
eg
puc
higher
percent
initi
replic
cycl
complet
plasmid
copi
number
reduc
sequenc
caus
inhibit
dna
polymeras
iii
replic
proteindna
complex
assembl
replic
termini
ter
repressor
bind
sequenc
mcglynn
guy
well
stabl
rnadna
hybrid
unusu
dna
structur
eg
internalribosom
entri
site
levi
strong
converg
promot
lead
head
transcriptionrepl
collis
reduc
copi
number
review
mirkin
mirkin
optim
vector
higher
copi
number
due
reduct
factor
exampl
plasmid
figur
chimer
promot
increas
plasmid
copi
number
fold
versu
altern
vector
gwiz
ferment
yield
gl
induc
fedbatch
process
see
section
vector
high
eukaryot
express
produc
replic
intermedi
problem
number
minim
vector
see
section
section
dna
vaccin
vector
design
issu
affect
qualiti
yield
regulatori
complianc
discuss
section
design
criteria
compil
flowchart
design
synthet
gene
insert
nick
associ
rich
region
cruciform
breath
suscept
endogen
singl
strand
nucleas
result
high
percentag
open
circular
plasmid
bacteri
host
endosom
mediat
nucleas
digest
mammalian
cell
azzoni
et
al
palindrom
sequenc
unstabl
direct
invert
repeat
direct
repeat
mutat
hot
spot
especi
cell
grown
stationari
phase
propag
ribeiro
et
al
unusu
dna
structur
form
run
potenti
z
dnaform
altern
pyrimidinepurin
sequenc
cpg
repeat
sequenc
bichara
et
al
grich
sequenc
may
form
tetraplex
structur
oligopyrimidin
oligopurin
sequenc
may
form
triplex
dna
plasmid
contain
z
dna
form
region
unstabl
intramolecular
triplex
region
reduc
plasmid
supercoil
batch
ferment
cook
et
al
presum
due
endogen
nucleas
mediat
nick
triplexform
singl
strand
dna
region
structur
must
retain
vector
revers
orient
element
rel
replic
origin
may
allevi
propag
problem
exampl
gc
rich
tgg
repeat
inhibit
plasmid
replic
tgg
strand
form
templat
lag
strand
synthesi
possibl
due
tetraplex
structur
form
grich
strand
pan
leach
reduc
plasmid
size
elimin
extran
dna
increas
potenc
remov
antigen
peptid
meet
regulatori
guidanc
caus
new
problem
replic
tend
termin
intern
ribosom
entri
site
ire
eukaryot
enhanc
repeat
region
eg
cmv
promot
termin
enhanc
orient
origin
close
parallel
cmv
promot
result
product
linear
fragment
call
replic
intermedi
interfer
perhap
due
secondari
structur
fortuit
bind
bacteri
protein
levi
phenomenon
seen
high
copi
plasmid
arrang
low
copi
plasmid
make
detect
intermedi
new
minim
dna
vaccin
vector
invitrogen
carlsbad
ca
contain
cmv
promot
replic
origin
close
proxim
due
size
reduct
vector
produc
replic
intermedi
thu
reduc
qualiti
plasmid
produc
bacteri
host
levi
presenc
replic
intermedi
readili
observ
extra
small
band
difficult
remov
downstream
process
purifi
plasmid
prepar
gener
replic
intermedi
problem
larger
vector
gwiz
genlanti
san
diego
ca
hartikka
et
al
optim
reduc
size
william
carn
unpublish
observ
configur
minim
vector
form
replic
intermedi
shown
figur
william
plasmid
recombin
independ
recbcd
mediat
recadepend
recf
pathway
recbcd
major
enzym
respons
degrad
linear
dna
e
coli
recbcd
degrad
arrest
chi
site
recbcd
direct
recruit
reca
chi
site
stimul
homolog
recombin
presenc
chi
site
plasmid
promot
recf
independ
recombin
recbcd
pathway
reca
sbcb
wild
type
cell
zaman
bole
oligopyrimidin
oligopurin
sequenc
plasmid
increas
dimer
presum
format
unusu
dna
structur
kato
dcm
e
coli
dna
methylas
methyl
intern
cytosin
residu
recognit
sequenc
methyl
cytosin
mutagen
thymin
certain
genet
background
mutat
dcm
gene
elimin
ccatgg
sequenc
reduc
methyl
possibl
reduc
mutat
rate
plasmid
dna
effect
dcm
methyl
express
immunogen
unknown
see
section
discuss
element
limit
plasmid
yield
qualiti
result
plasmid
carri
lower
copi
number
cell
gener
replic
origin
need
protect
readthrough
transcript
adjac
gene
exampl
cryptic
promot
antigen
gene
insert
prevent
plasmid
destabil
reduc
copi
number
engel
meyer
may
accomplish
inclus
shield
transcript
termin
optim
orient
composit
element
eastman
durland
brosiu
william
et
al
exampl
transcript
termin
shield
prokaryot
replic
origin
insert
mediat
transcript
readthrough
reduc
insert
toxic
due
eukaryot
gene
transcript
brosiu
chen
et
al
chen
morrison
gene
insert
may
contain
protein
peptid
toxic
host
cell
hydrophob
membran
span
peptid
particularli
toxic
bacteria
translat
insert
encod
toxic
peptid
may
prevent
introduct
revers
orient
promot
insert
gener
translationdisrupt
antisens
rna
weiner
et
al
review
saida
et
al
howev
insert
born
toxic
peptid
express
sens
strand
exampl
bacteri
toxic
influenza
serotyp
antigen
gene
mediat
express
antisens
strand
william
unpublish
observ
altern
plasmid
stabil
improv
product
achiev
insert
intron
disrupt
bacteri
product
known
toxic
protein
boyd
et
al
bacteri
replic
block
defin
termin
ter
site
site
contain
core
conserv
sequenc
less
conserv
flank
review
neylon
et
al
ter
site
within
replic
origin
essenti
normal
replic
termin
addit
site
may
detriment
introduct
plasmid
dna
human
requir
special
consider
address
sever
recent
world
heath
organ
us
food
drug
administr
fda
european
agenc
evalu
medicin
product
emea
regulatori
draft
guidanc
emea
emea
fda
fda
content
guidanc
review
schalk
et
al
glent
wessel
key
issu
consid
plasmid
design
discuss
reduc
chanc
chromosom
integr
plasmid
contain
signific
homolog
target
organ
genom
determin
blast
search
specifi
search
short
nearli
exact
match
relev
genom
recombin
natur
virus
insid
vaccin
person
also
possibl
exampl
cmv
promot
infect
cmv
viru
howev
consid
lower
risk
dna
vaccin
convent
vaccin
schalk
et
al
rais
specif
concern
fda
emea
regulatori
guidanc
except
recombin
event
would
restor
viral
virul
vector
contain
bacteri
dna
uptak
sequenc
preferenti
transform
pasteurellacea
neisseriacea
speci
schalk
et
al
see
section
spacer
junk
sequenc
encod
defin
function
remov
difficult
accomplish
sinc
minor
variat
vector
backbon
dramat
effect
bacteri
yield
qualiti
eukaryot
express
immunogen
see
section
region
encod
antigen
peptid
present
includ
cryptic
open
read
frame
orf
bacteri
eukaryot
sequenc
may
express
eukaryot
cell
van
hall
et
al
schirmbeck
et
al
remov
spacer
junk
sequenc
use
rnabas
select
marker
ie
elimin
kanr
orf
reduc
risk
particular
concern
use
hepat
viral
enhanc
hepat
genom
highli
compact
enhanc
function
overlap
antigen
protein
code
region
yuh
ting
exampl
deriv
fuller
contain
singl
copi
hbv
posttranscript
regulatori
element
pre
immedi
downstream
stop
codon
prior
transcript
termin
element
includ
increas
mrna
nuclear
export
howev
pre
also
encod
amino
acid
fragment
hepat
c
viru
hcv
polymeras
gene
design
within
eukaryot
express
cassett
type
design
demonstr
gener
tcell
reactiv
mhc
epitop
cryptic
orf
schirmbeck
et
al
antigen
region
might
significantli
alter
immun
respons
individu
prior
exposur
memori
tcell
hepat
origin
host
restrict
e
coli
close
relat
gram
neg
bacteria
case
origin
replic
initi
protein
may
delet
plasmid
integr
genom
host
advantag
sinc
reduc
size
plasmid
origin
restrict
host
rang
plasmid
product
strain
contain
activ
express
plasmid
system
configur
tabl
greatli
reduc
concern
plasmid
contain
therapeut
gene
antibiot
resist
marker
see
taken
propag
enter
bacteria
patient
dissemin
therapeut
gene
eg
growth
factor
resist
marker
see
manner
would
undesir
use
antibiot
resist
marker
gener
discourag
use
vivo
effect
need
evalu
exampl
emea
guidanc
indic
lack
express
mammalian
cell
verifi
due
regulatori
concern
ampicillin
resist
accept
due
concern
hyper
reactiv
patient
lactam
antibiot
resist
kanamycin
encod
gene
neomycin
phosphotransferas
iii
nptiii
aph
iii
avoid
sinc
also
confer
resist
amikacin
reserv
antibiot
emea
vector
util
either
nptii
eg
nptia
eg
pdnavaccultra
nptii
aph
iia
gene
confer
resist
neomycin
b
kanamycin
neamin
geneticin
amikacin
ineffici
substrat
siregar
et
al
nptia
aph
ia
gene
confer
resist
kanamycin
neomycin
b
neamin
lividomycin
geneticin
amikacin
butirosin
weakli
inhibit
enzym
weak
phosphatas
activ
toward
siregar
et
al
altern
vector
specif
ant
kanr
marker
also
develop
snyder
satishchandran
antigen
gene
enzymat
activ
virul
issu
incorpor
inactiv
attenu
mutat
respect
consid
exampl
multipl
basic
amino
acid
motif
influenza
hemagluttinin
cleavag
site
pqrerrrkkrgl
correl
pathogen
replac
correspond
region
pqresrgl
sever
nonpathogen
influenza
strain
protect
virul
factor
gene
transfer
immun
infect
non
pathogen
virus
transient
antibodi
respons
dna
observ
dna
bind
protein
hivnef
hepat
c
viru
core
rais
concern
immun
respons
dna
may
induc
proteinnucl
acid
complex
review
schalk
et
al
incorpor
mutat
inactiv
dna
bind
elimin
nuclear
local
may
decreas
risk
dna
protein
complex
well
cytoplasm
protein
improv
proteosom
process
present
mhci
compar
nuclear
local
protein
optim
vector
valid
new
version
creat
substitut
new
gene
backbon
vector
design
criteria
describ
typic
allow
clone
gene
interest
exist
intron
contain
transcript
intron
increas
mrna
export
subsequ
express
level
immedi
downstream
intron
exon
optim
kozak
sequenc
conform
consensu
gccrccaugg
r
g
aug
gene
start
codon
sali
gtcgac
function
kozak
sequenc
often
use
restrict
site
clone
gene
vector
kozakatg
gtcgacatg
fusion
gene
clone
start
atg
codon
immedi
downstream
kozak
sequenc
nonn
amino
acid
may
includ
codon
two
sinc
highli
express
gene
atgg
start
altern
gene
clone
without
atg
codon
downstream
signal
sequenc
tpa
direct
protein
endoplasm
reticulum
secret
secret
often
improv
immun
respons
use
valid
vector
backbon
may
reduc
extent
requir
preclin
test
version
incorpor
new
gene
exampl
fda
guidanc
indic
biodistribut
studi
may
waiv
dna
vaccin
produc
insert
novel
gene
plasmid
vector
previous
document
accept
biodistributionintegr
profil
guidanc
indic
biodistribut
persist
studi
requir
unless
substanti
experi
alreadi
gain
almost
ident
similar
product
emea
guidanc
indic
previou
experi
vector
system
allow
optim
focus
nonclin
studi
safeti
studi
use
dna
vaccin
vector
differ
insert
demonstr
similar
biodistribut
sheet
et
al
toxicolog
sheet
et
al
therefor
critic
new
antigen
gene
well
design
avoid
unnecessari
insertspecif
regulatori
issu
therapeut
antigen
gene
tradit
transfer
genom
dna
construct
directli
dna
vaccin
vector
howev
express
unmodifi
gene
insert
especi
dramat
differ
codon
usag
pattern
compar
target
organ
often
suboptim
gene
synthesi
technolog
eg
geneart
regensburg
germani
menlo
park
ca
becom
highli
afford
review
wu
et
al
recommend
dna
vaccin
intend
potenti
licensur
new
gene
insert
design
de
novo
compat
regulatori
complianc
improv
eukaryot
express
made
synthet
flowchart
design
new
insert
figur
discuss
mani
factor
relat
vector
design
also
import
creat
new
insert
exist
vector
determin
desir
protein
amino
acid
sequenc
pathogen
contain
variou
serotyp
amino
acid
variat
may
involv
defin
consensu
immunogen
laddi
et
al
highli
express
gene
start
atgg
sequenc
includ
metgli
metala
metval
metglu
metasp
dipeptid
amino
termini
bioinformat
util
ensur
oncogen
sequenc
exist
predict
protein
emea
fusion
protein
contain
two
antigen
eg
figur
util
advanc
design
coimmun
one
target
organ
determin
target
exampl
gene
secret
antigen
determin
secret
retain
remov
retain
determin
nativ
heterolog
secret
sequenc
eg
tpa
util
advantag
tpa
extens
prior
clinic
experi
demonstr
perform
high
yield
product
secret
protein
varieti
target
gene
inactiv
nuclear
local
sequenc
consid
dna
bind
protein
design
synthet
gene
use
codon
optim
softwar
optim
puigbo
et
al
gene
design
softwar
describ
villalobo
et
al
design
defin
sequenc
elimin
final
gene
sequenc
sequenc
exclud
includ
agg
codon
underrepres
highli
express
human
gene
huang
et
al
chi
site
ter
site
core
dcm
site
ccagg
cctgg
methyl
site
aacnnnnnngtgc
polyadenyl
site
aataaa
attaaa
tata
box
tataataa
immunosuppress
telomer
ttaggg
motif
gursel
et
al
pasteurellacea
neisseriacea
dna
uptak
sequenc
gccgtctgaa
aagtgcggt
acaagcggtc
review
bakkali
flank
restrict
site
util
clone
vector
b
design
cpg
content
immunostimulatori
context
krieg
modifi
desir
design
consid
protein
secondari
structur
inform
may
encod
mrna
codon
usag
bia
gu
et
al
bioinformat
screen
put
synthet
gene
sequenc
identifi
undesir
sequenc
bacteri
propag
rich
region
tt
ta
cluster
also
encod
uu
ua
eukaryot
rnase
l
cleavag
site
region
unlik
codon
optim
gc
rich
gene
mammalian
express
hairpin
zdna
form
altern
purinepyrimidin
repeat
oligopyrimidin
oligopurin
sequenc
web
base
softwar
util
screen
structur
zhunt
zdna
ho
et
al
emboss
program
einvert
palindrom
equicktandem
etandem
detect
invert
repeat
palindrom
tandem
repeat
respect
rice
et
al
dna
cruciform
websidd
bi
betham
bioinformat
screen
put
synthet
gene
identifi
undesir
sequenc
eukaryot
express
cryptic
splice
site
acceptor
donor
branch
site
could
lead
aberr
splice
bp
dsrna
invert
repeat
identifi
step
could
lead
rnai
mediat
gene
silenc
cryptic
microrna
target
could
lead
inadvert
cell
specif
regul
sequenc
identifi
bioinformat
exampl
intern
splice
site
pertea
et
al
microrna
see
ioshikh
et
al
review
avail
program
determin
secondari
structur
end
gene
screen
use
program
mfold
zucker
rna
fold
pattern
bp
gene
would
present
rna
produc
final
vector
ie
fuse
vector
encod
splice
leader
rna
select
optim
version
substanti
secondari
structur
region
kozakatg
start
site
blast
search
target
organ
genom
specifi
search
short
homolog
region
modifi
sequenc
remov
region
signific
ident
translat
entir
insert
read
frame
forward
revers
search
potenti
cryptic
open
read
frame
altern
frame
necessari
modifi
creat
stop
codon
altern
frame
make
synonym
codon
chang
necessari
incorpor
two
tandem
stop
codon
combin
tga
taa
ensur
correct
termin
prevent
read
translat
gene
synthes
clone
vector
occasion
plasmid
insert
meet
design
criteria
low
yield
toxic
bacteri
host
sinc
bioinformat
effect
identifi
altern
dna
structur
like
problem
due
express
toxic
peptid
cryptic
bacteri
promot
howev
correl
weak
bacteri
promot
insert
predict
variou
bioinformat
program
plasmid
product
observ
william
unpublish
observ
may
due
limit
search
algorithm
vector
often
produc
use
low
metabol
burden
seedstock
ferment
process
see
section
cryptic
antisens
eukaryot
promot
may
also
detriment
make
antisens
rna
lead
rna
interfer
gene
silenc
util
improv
bioinformat
program
detect
bacteri
promot
review
wang
benham
human
promot
review
abeel
et
al
may
increas
insert
design
success
rate
futur
dna
vaccin
plasmid
typic
manufactur
use
nih
automat
exempt
attenu
e
coli
strain
listner
et
al
cook
et
al
singer
et
al
lahijani
et
al
e
coli
b
strain
recent
demonstr
high
yield
plasmid
product
host
phue
et
al
genotyp
cell
line
shown
tabl
auxotroph
strain
suitabl
growth
semi
defin
media
product
minim
media
sinc
requir
expens
supplement
util
defin
media
plasmid
product
huber
et
al
listner
et
al
defin
media
growth
critic
strain
mucoid
exampl
gal
strain
produc
addit
capsul
colon
acid
product
minim
media
mucoid
cultur
difficult
harvest
foul
downstream
process
colon
acid
product
block
mutagenesi
gale
gene
therapeut
product
plasmid
strain
contain
conjug
plasmid
undesir
regulatori
perspect
due
potenti
conjug
enhanc
transfer
genet
materi
environment
organ
well
blue
white
select
reason
inclus
f
plasmid
sever
strain
requir
product
problem
address
innov
way
pcor
vector
host
inactiv
f
factor
trad
conjug
coupl
protein
soubrier
et
al
illustr
tabl
variou
product
host
differ
methyl
pattern
sinc
describ
methyl
effect
eukaryot
express
immunogen
import
determin
optim
methyl
pattern
maintain
plasmid
product
host
pattern
subsequ
preclin
clinic
develop
emea
dcm
function
dispens
damstrain
use
larg
scale
plasmid
product
dam
methyl
involv
multipl
cellular
process
includ
chromosom
replic
review
lobnerolesen
et
al
damstrain
mutagen
glickman
radman
marinu
et
al
damstrain
stratagen
la
jolla
ca
avail
small
scale
plasmid
product
evalu
dam
methyl
effect
function
determin
dam
site
remov
critic
region
vector
sever
studi
perform
identifi
optim
strain
plasmid
product
exampl
select
best
strain
ferment
product
evalu
panel
strain
product
three
differ
plasmid
use
lb
shake
flask
media
one
plasmid
strain
evalu
semi
defin
batch
ferment
significantli
plasmid
product
shake
flask
poorli
predict
ferment
product
one
poorer
ferment
produc
studi
mgod
l
supercoil
intermedi
mgod
l
supercoil
highest
mg
od
l
supercoil
contrast
induc
semi
defin
batch
ferment
process
high
produc
strain
extens
shake
flask
evalu
plasmid
specif
yield
supercoil
host
strain
three
differ
puc
origin
base
plasmid
kb
gwizgfp
kb
kb
report
yau
et
al
appropri
product
plasmid
strain
near
supercoil
plasmid
high
specif
yield
plasmid
contrast
strain
found
poor
supercoil
product
yield
one
plasmid
exampl
plasmid
yield
high
supercoil
inconsist
recent
recaenda
demonstr
produc
high
yield
gl
predominantli
supercoil
plasmid
gwiz
deriv
plasmid
induc
process
phue
et
al
contrast
yau
et
al
shake
flask
result
poor
produc
attribut
reca
gene
product
phue
et
al
studi
demonstr
strain
specif
plasmid
product
shake
flask
poorli
predict
ferment
product
strain
perform
vari
differ
ferment
process
cell
line
product
creat
transform
relev
cell
line
dilut
prepar
plasmid
ensur
cell
transform
singl
plasmid
molecul
individu
coloni
screen
plasmid
qualiti
ie
monom
quantiti
plasmid
yield
prior
creat
master
work
cell
bank
care
taken
high
copi
puc
origin
plasmid
avoid
stationari
phase
high
temperatur
eg
use
rela
mutant
strain
condit
creat
high
plasmid
copi
number
increas
metabol
burden
induct
mutagen
repair
pathway
exampl
high
copi
plasmid
reduc
stationari
phase
viabil
toxic
correl
size
dna
insert
transcript
insert
cheah
et
al
growth
transform
cell
seed
stock
creation
lower
temperatur
eg
result
reduc
plasmid
dimer
improv
downstream
ferment
product
yield
tradit
poor
yield
plasmid
carn
et
al
insert
transpos
element
plasmid
product
may
issu
process
plasmid
prather
et
al
report
high
frequenc
transposit
insert
element
promot
neo
select
marker
cell
line
creation
defin
media
posfai
et
al
identifi
transposit
plasmid
propag
standard
e
coli
strain
thu
cell
bankferment
process
must
care
engin
limit
insert
sequenc
activ
especi
defin
media
process
plasmid
ferment
process
ideal
maxim
volumetr
yield
mgl
specif
yield
mgg
dcw
mgod
l
high
qualiti
supercoil
plasmid
high
volumetr
yield
facilit
smaller
econom
ferment
high
specif
yield
drastic
improv
plasmid
puriti
yield
downstream
process
ferment
process
also
optim
retain
high
percentag
supercoil
plasmid
sinc
plasmid
form
eg
nick
difficult
remov
purif
consid
undesir
isoform
regulatori
agenc
fda
media
optim
need
care
perform
sinc
differ
growth
media
carbon
nitrogen
ratio
dramat
affect
cell
harvest
lysi
characterist
okennedi
et
al
cell
storag
condit
kong
et
al
thu
ferment
media
process
need
care
optim
plasmid
yield
plasmid
qualiti
supercoil
compat
result
cell
harvest
lysi
temperatur
employ
select
induc
temperatur
sensit
plasmid
amplif
known
origin
mutat
puc
mutat
well
suit
applic
sinc
copi
number
shift
low
level
high
level
higher
copi
number
puc
plasmid
obtain
temperatur
shift
rather
restrict
growth
fedbatch
ferment
mutat
rnaii
primer
puc
may
total
resist
rnai
inhibit
runaway
replic
partial
resist
possibl
uncharg
trnamedi
rnai
inhibit
see
section
restrict
grown
amino
acid
starv
cell
contribut
runaway
replic
inde
uncharg
trnamedi
rnai
inhibit
increas
stationari
phase
plasmid
yield
lower
copi
base
origin
media
process
design
increas
level
uncharg
trna
may
applic
improv
puc
ferment
review
wang
et
al
transcript
initi
weak
rnaii
primer
promot
may
key
rate
limit
factor
affect
puc
plasmid
copi
number
product
yield
howev
unregul
rnaii
promot
mutat
altern
promot
may
increas
copi
number
increas
metabol
burden
critic
earli
growth
phase
ultim
reduc
product
see
section
fedbatch
ferment
figur
cell
inocul
initi
volum
medium
contain
nonlimit
nutrient
initi
concentr
limit
substrat
batch
growth
phase
control
feed
limit
nutrient
begin
cell
consum
initi
amount
substrat
allow
control
growth
rate
max
fedbatch
phase
feed
strategi
either
feedback
control
eg
dostat
ph
stat
metabol
activ
biomass
concentr
substrat
concentr
predetermin
eg
constant
linear
stepwis
exponenti
feed
metabol
overflow
excess
substrat
reduc
avoid
excess
format
inhibitori
acet
review
carn
carn
william
ferment
product
yield
issu
origin
vector
moder
yield
yield
fedbatch
ferment
use
minim
media
report
pcor
vector
system
product
altern
origin
contain
vector
deriv
pcpg
invitrogen
carlsbad
ca
either
e
coli
strain
tabl
invivogen
san
diego
ca
also
similarli
low
ferment
yield
mgl
low
specif
yield
mg
plasmidg
dri
cell
weight
dcw
hebel
et
al
mutagenesi
replic
protein
select
increas
copi
number
use
make
new
product
strain
report
yield
mgl
mg
plasmidg
dcw
soubrier
mgl
od
soubrier
et
al
mg
plasmidg
dcw
assum
g
od
l
yield
fold
reduc
compar
obtain
optim
puc
origin
vector
reach
gl
total
dri
cell
weight
mg
plasmidg
dcw
see
sever
batch
fedbatch
plasmid
ferment
process
describ
provid
yield
mgl
plasmid
mg
plasmidg
dcw
puc
origin
plasmid
lahijani
et
al
schmidt
et
al
review
carn
william
carn
hoar
et
al
prather
et
al
shamlou
high
yield
fedbatch
process
gl
mg
plasmidg
dcw
describ
enabl
cost
effect
plasmid
manufactur
process
coupl
reduc
growth
rate
plasmid
product
high
copi
replic
origin
cell
grown
listner
et
al
huber
et
al
singer
et
al
review
carn
william
reduc
growth
rate
increas
copi
number
linchao
bremer
seo
bailey
supercoil
plasmid
retent
plasmid
yield
harvest
listner
et
al
process
compar
tabl
huber
et
al
process
compar
sinc
maximum
specif
plasmid
yield
occur
rel
earli
process
lower
later
biomass
accumul
product
yield
mgl
mg
plasmid
lod
mgg
dcw
dcw
puc
base
pntcultra
plasmid
obtain
fedbatch
ferment
process
plasmid
dna
process
predominantli
supercoil
monom
shift
fedbatch
ferment
growth
arrest
od
report
also
reach
dcw
specif
yield
danquah
ford
thu
highest
specif
yield
plasmidbiomass
obtain
date
dcw
obtain
optim
fedbatch
process
studi
replic
machineri
overproduct
chromosom
dna
ie
driven
integr
plasmid
runaway
replicon
bernand
et
al
show
upper
limit
chromosom
dna
content
toler
cell
may
fold
increas
studi
runaway
r
plasmid
achiev
total
dna
plasmid
rel
chromosom
fold
increas
total
dna
standard
protein
thu
util
host
replic
system
current
strain
addit
replic
capac
direct
plasmid
product
plasmid
yield
chromosom
total
dna
uhlin
et
al
may
theoret
possibl
may
repres
upper
limit
cell
toler
maximum
obtain
varieti
differ
size
plasmid
associ
viabil
loss
alter
cell
morpholog
nordstrom
nordstrom
uhlin
project
yield
dcw
difficult
sinc
number
genom
per
cell
cell
size
depend
strain
growth
rate
media
composit
exampl
unrestrict
logarithm
grow
cultur
contain
even
copi
chromosom
skarstad
et
al
rapidli
grow
cell
much
larger
growthrestrict
cell
akerlund
et
al
churchward
et
al
smaller
slow
grow
cell
contain
chromosom
dnadcw
logarithm
grow
larger
cell
contain
chromosom
dnadcw
review
bremer
denni
r
plasmid
runaway
replic
studi
gener
perform
exponenti
grow
cultur
would
predict
plasmid
dnadcw
maximum
limit
ie
chromosom
assum
chromosom
dnadcw
cours
assum
capac
cell
dna
vari
depend
strain
cell
size
growth
rate
gener
lower
growth
rate
favor
reduc
select
plasmid
contain
cell
plasmid
presenc
reduc
maximum
growth
rate
optim
temperatur
e
coli
growth
lower
temperatur
may
use
batch
phase
fedbatch
ferment
caus
reduc
maximum
specif
growth
rate
reduc
plasmid
copi
number
combin
reduc
metabol
burden
plasmid
loss
batch
phase
minim
growth
differ
plasmidcontain
plasmidfre
cell
also
prevent
accumul
uncharg
trna
unwant
earli
plasmid
amplif
antisens
inhibit
rnai
plasmid
product
induc
temperatur
shift
biomass
product
figur
b
altern
strategi
develop
reduc
plasmid
mediat
metabol
stress
aim
allevi
growth
rate
inhibit
exampl
engin
strain
overproduc
intermediari
pentosephosph
pathway
requir
maintain
nucleotid
precursor
pool
plasmid
replic
protein
product
overexpress
dehydrogenas
zwf
partial
allevi
plasmid
mediat
growth
rate
reduct
flore
et
al
isomeras
rpia
gene
product
downregul
cell
contain
high
copi
plasmid
overexpress
rpia
improv
plasmid
copi
number
howev
overexpress
zwfrpia
induc
fedbatch
process
increas
rate
plasmid
induct
affect
final
plasmid
yield
indic
nucleotid
precursor
pool
limit
plasmid
copi
number
inactiv
global
regul
frur
increas
growth
rate
plasmid
bear
cell
ow
et
al
copi
number
mggdcw
ow
et
al
effect
frur
knockout
plasmid
product
low
metabol
burden
high
yield
process
unknown
protein
overexpress
plasmid
also
place
metabol
load
host
cell
increas
oxygen
demand
kay
et
al
may
limit
plasmid
product
review
ricci
hernandez
glick
exampl
ferment
kanamycin
resist
kanr
plasmid
batch
defin
media
ferment
process
result
reduc
growth
rate
biomass
overflow
metabol
overexpress
kanr
gene
product
total
protein
specul
caus
effect
rozkov
et
al
plasmid
protein
express
reduc
growth
biomass
accumul
lower
copi
number
copi
numberdepend
kanr
product
describ
growth
reduc
temperatur
eg
batch
phase
elimin
need
engin
cell
reduc
metabol
burden
biomass
accumul
phase
sinc
metabol
burden
inher
reduc
elimin
process
high
metabol
burden
earli
growth
may
account
gener
poor
plasmid
yield
ferment
process
use
varieti
media
sinc
typic
perform
throughout
review
carn
william
prather
et
al
consist
recent
report
compar
versu
growth
batch
phase
subsequ
fedbatch
product
restrict
growth
rate
product
yield
batch
phase
growth
dramat
improv
mgl
versu
mgl
omahoni
et
al
interestingli
creation
seed
stock
transform
perform
rather
also
dramat
increas
plasmid
yield
product
seed
stock
viabil
tradit
low
yield
plasmid
william
et
al
carn
et
al
indic
gener
benefit
plasmid
product
reduc
temperatur
growth
step
prior
growth
control
restrict
fedbatch
stage
low
metabol
burden
seed
stockferment
process
allow
gener
product
spectrum
vector
good
bad
design
critic
contract
manufactur
control
incom
vector
design
method
design
licens
dna
vaccin
vector
combin
high
yield
integr
bacteri
product
increas
express
mammalian
cell
present
new
vector
requir
extens
preclin
test
valid
safeti
perform
prior
clinic
use
regulatori
test
burden
followon
product
reduc
combin
care
design
synthet
gene
exist
valid
vector
backbon
util
recent
develop
low
metabol
burden
seed
stock
ferment
strategi
even
poorli
design
vector
produc
usabl
yield
optim
vector
manufactur
high
yield
exceed
gl
specif
plasmid
yield
total
dcw
specif
yield
may
approach
maximum
combin
highyield
low
metabol
stress
process
altern
cell
line
capabl
produc
fold
biomass
fedbatch
ferment
review
shiloach
fass
may
improv
plasmid
yield
gl
collect
dna
vaccin
efficaci
cost
good
improv
use
new
vector
process
combin
improv
potenc
econom
manufactur
annot
restrict
map
critic
featur
mrna
leader
utr
chimer
promot
kanr
gene
function
domain
origin
pasbl
rnaii
promot
rnase
h
cleavag
site
indic
vector
target
fusion
antigen
antigen
proteosom
degrad
fusion
cterminu
ubiquitin
b
plasmid
dna
replic
lead
strand
rna
polymeras
transcript
rnaii
either
form
replic
drive
rloop
rna
dna
hybrid
origin
left
nonproduct
interact
antisens
rnai
copi
number
regul
right
rloop
cleav
rnase
h
result
oh
serv
primer
dna
pol
dna
synthesi
replic
lead
strand
expos
type
induc
fedbatch
plasmid
product
ferment
process
b
e
coli
strain
plasmid
induc
fedbatch
ferment
growth
plasmid
yield
profil
ferment
shift
induc
plasmid
product
plasmid
yield
reach
mgl
increas
plasmid
qualiti
enda
periplasm
nonspecif
nucleas
protect
cell
invad
dna
howev
upon
lysi
enda
degrad
plasmid
dna
reca
reduc
plasmid
recombin
rela
elimin
stringent
respons
allow
slow
growth
sbcc
sbcd
operon
encod
nucleas
creat
doubl
strand
break
hairpin
repair
use
recombin
pathway
connelli
leach
sbcc
sbcd
mutant
stabil
plasmid
palindrom
minimum
stem
loop
chalker
et
al
connelli
et
al
tgg
trinucleotid
repeat
pan
leach
sbcc
mutant
reca
recq
helicas
requir
palindrom
viabil
perhap
allow
replic
bypass
secondari
structur
cromi
et
al
protein
mutat
increas
copi
number
plasmid
harbor
gamma
origin
replic
relat
cell
line
without
uida
dmlui
